Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

NCT01167881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1549

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 10773
DRUG: Glimepiride
DRUG: Placebo
DRUG: Placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]